AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 74 filers reported holding AURA BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 2.25 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $31,918,866 | 13.40% |
| Regency Capital Management Inc.\DE | 554,286 | $5,820,003 | 6.69% |
| Decheng Capital Management III (Cayman), LLC | 293,333 | $3,079,997 | 1.15% |
| Matrix Capital Management Company, LP | 5,362,870 | $56,310,135 | 1.08% |
| Monashee Investment Management LLC | 131,640 | $1,382,220 | 0.60% |
| Nantahala Capital Management | 798,751 | $8,386,886 | 0.54% |
| Eventide Asset Management | 2,251,368 | $23,639,364 | 0.47% |
| Rock Springs Capital Management LP | 1,019,757 | $10,707,449 | 0.26% |
| Artal Group S.A. | 410,000 | $4,305 | 0.24% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,132,739 | $22,393,760 | 0.05% |